Results 41 - 60 of 189.

Health - Life Sciences - 16.08.2022
Discovery of a genetic factor that quadruples the risk of end-stage renal failure!
Discovery of a genetic factor that quadruples the risk of end-stage renal failure!
In brief: Chronic kidney disease (CKD) affects over 10% of the world's population, including over one million people in Belgium. Genetic mutations are a major cause of CKD. Some mutations are very rare and have very severe effects on the kidney. Others are much and have barely detectable effects. For the first time, a UCLouvain team has discovered an intermediate-effect genetic mutation, present in about one in 1,000 people, that strongly increases the risk of CKD.

Health - 30.05.2022
Nutritional supplement reduces prevalence of low birth weight babies
Nutritional supplement reduces prevalence of low birth weight babies
Ghent University research in Burkina Faso: fortified food supplements increase the chance of a healthier baby Every parent around the globe wishes for a healthy baby.

Health - Social Sciences - 17.05.2022
Researcher Koen Byttebier writes book on Covid-19 and capitalism
Successful and unsuccessful approaches to the pandemic by Western governments Tuesday, May 17, 2022 — Since 2020, the world has been experiencing the consequences of the Covid-19 pandemic. The cause is obviously a virus, but the degree of its spread, and the associated number of infections and deaths, is largely dependent on socio-economic factors.

Health - Environment - 11.05.2022
You don’t cut down an old tree: KU Leuven study demonstrates connection between large urban trees and human health
Not every type of greenery in an urban environment has the same positive effect on people. One large tree with a robust crown has more impact than ten young trees. That is the conclusion of a large-scale study by KU Leuven that was published today in the influential journal Environmental Health Perspectives.

Health - 10.05.2022
Blocking spike captors to counter Covid
In brief: It's a very promising world first! Scientists at University of Louvain (UCLouvain) have managed to identify the key that allows the Covid virus to attack cells Better still, they have also managed to close the lock to block the virus and prevent its interaction with the cell, in other words, to prevent infection This discovery raises a huge hope : that of developing an antiviral, in the form of an aerosol , which would help to eradicat

Pharmacology - Health - 03.05.2022
Antibiotics impact gut microbiome and antimicrobial resistance
Antibiotics impact gut microbiome and antimicrobial resistance
Antibiotics are commonly used to treat infections and ensure the safety of surgical procedures. However, their overuse has led to the emergence and spread of resistant bacteria, resulting in an -arms race- whereby ever more potent drugs are becoming a necessity.

Health - Pharmacology - 21.04.2022
The why behind mild COVID-19
All-Luxembourg study helps to anticipate a personal COVID-19 health trajectory From the start of the COVID-19 pandemic, the majority of published studies have focused on severe COVID-19 patients in order to understand the causes of critical illness. However, it is equally, if not more important to understand the protective immune factors in our body.

Health - Pharmacology - 12.04.2022
B or not to B: Insights in the regulation of anti-viral immunity
Researchers delve into the inner workings of the antibody immune response, finding key differences in the metabolism of two closely related immune cell subsets. Protection against viral diseases is a key role of our body's immune response, where antibodies are generated to seek out invading species and either neutralise or mark them for destruction.

Life Sciences - Health - 17.03.2022
Midbrain single-cell sequencing to understand Parkinson’s Disease
Researchers from the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg, in collaboration with the Max Planck Institute for Molecular Genetics in Berlin, investigated the different cell types present in the human midbrain to better understand their respective role in Parkinson's disease.

Health - Pharmacology - 09.03.2022
VUB spin-off Lavima Fertility develops novel fertility treatment that reduces risks and burden
Couples unable to get pregnant naturally often resort to In Vitro Fertilisation (IVF) to fulfil their desire to have children. To obtain mature eggs for IVF, women typically undergo ovarian stimulation with hormones which can be very burdensome. A team of scientists of the Follicle Biology (FOBI) Research Laboratory at the Vrije Universiteit Brussel (VUB) in collaboration with the UZ Brussel fertility clinic has succeeded in developing a novel method for In Vitro Maturation (IVM) of oocytes, called CAPA-IVM.

Sport - Health - 04.03.2022
The brain of fatigued athletes works differently during functional balance tests used to determine sports injury risk
Researchers from the Human Physiology and Sports Physiotherapy research group at the Vrije Universiteit Brussel have shown that physical fatigue affects an athlete's brain when performing a functional balance test. The accuracy with which a representative group of recreational athletes responded to a novel reactive balance test was measured, alongside their response time.

Health - Life Sciences - 03.03.2022
Unexpected element in aging process discovered
VUB professor Ann Massie and her research group Neuro-Aging & Viro-Immunotherapy have published a surprising finding in an article in the leading journal Molecular Psychiatry. They have discovered a strategy that results in prolonged life expectancy and counteracts memory loss during the aging process.

Life Sciences - Health - 28.02.2022
Alternatives to animal testing on the rise
VUB, Sciensano, Flanders and Brussels call on scientists to share expertise on alternative testing methods via RE-Place platform A few years ago, the Flemish and Brussels Regions launched RE-Place , a platform for researchers to share their expertise on alternatives to animal testing.

Health - Pharmacology - 04.02.2022
VUB professor Bart Neyns takes initiative to establish Cancer Survivor Center
World Cancer Day, 4 February: Ex-cancer patients have to get used to life again Cancer patients who have survived serious treatment and are free of the disease often suffer an enormous psychological blow afterwards and find it difficult to pick up the thread of life again.

Health - Pharmacology - 04.02.2022
Four out of ten cancer survivors suffer from chronic pain
VUB research suggests pain education and lifestyle are important components of a multimodal approach to treat persistent pain Friday, February 4, 2022 — 4 February is #WorldCancerDay After cancer treatment, many patients continue to suffer from pain. About four out of ten cancer survivors have chronic pain complaints.

Health - Pharmacology - 02.02.2022
Amino acid proline key to promising new treatment strategy for myeloma patients
World Cancer Day, 4 February: Award-winning research on incurable blood cancer Researchers at the Vrije Universiteit Brussel, led by Eline Menu, have investigated how changes in metabolism contribute to cancer resistance and relapse.

Health - 01.02.2022
The eye as a window into heart disease
AI system can predict risk of heart attack based on retinal scan An international team of researchers have developed an AI system that can identify patients who are likely to have a heart attack over the next year. The system reads retinal scans that are already commonly used in eye clinics. Doctors have recognised that changes to the tiny blood vessels in the retina are indicators of broader vascular disease, including problems with the heart.

Health - Pharmacology - 01.02.2022
Predictive model should avoid need for surgery in rectal cancer
Two research groups from the Vrije Universiteit Brussel have established a collaboration in which they predict the response to the standard treatment for rectal cancer based on medical images (e.g.

Health - Pharmacology - 30.01.2022
Lactic acid weakens anti-tumour defences
In cancer research, it has long been known that lactic acid, or lactate, is produced in large quantities by cancer cells and that this lactic acid disrupts our defence against tumours.

Health - Life Sciences - 24.01.2022
Link between sugar metabolism and Parkinson's disease
Link between sugar metabolism and Parkinson’s disease
In brief: Parkinson's disease is the second most common neurodegenerative disease, but we still do not understand why this disease occurs. Scientists from the UCLouvain de Duve Institute have discovered a new type of molecular damage that is (glycolysis). They also discovered a mechanism that allows cells to prevent this type of damage.